Trial Information

Rheumatoid Arthritis
The Flex-V Study

We’re hoping to discover something…..the real you

We are conducting a clinical research study to test the safety and effectiveness of an investigational medication in patient with rheumatoid arthritis (RA) who were previously unsuccessfully treated with another medication called a tumor necrosis factor-alpha (TNF-a) inhibitor.

You may be able to participate in the flex-V Study if you:

are 18 years of age or older
have been diagnosed with RA for at least 6 months
have symptoms of active RA such as painful, swollen, and tender joints
were previously treated with at least one TNF-a inhibitor
are currently receiving treatment with a disease-modifying antirheumatic drug (DMARD) for at least 8 weeks (12 weeks if you are taking methotrexate).

If you are unsure which medication you are taking, please check with your doctor.

The Flex-V Study will last for up to 76 weeks. You will continue to take your DMARD therapy as usual throughout the study. The study will require regular visits to the study center so that the study doctors and nurses can monitor your RA symptoms and general health.

Taking part in the Flex-V Study will provide new information that will add to the current knowledge about RA treatment, which may potentially help other patients in the future.

For more information, or if you are interested in taking part in the Flex-V Study, please contact: Linda Weber, RN, at the Research Department, Bone and Joint Hospital at St. Anthony, at 405-979-7855, or www.RheumatoidArthritisStudy.com.

Bone and Joint Hospital at St. Anthony
1111 N. Dewey Avenue
Oklahoma City, OK 73103
Phone: 405-979-7854

View Map

Research Center Information: Bone and Joint Hospital at St. Anthony

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.